A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Clinical trial NCT07735637 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07735637
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-25
- Primary completion
- 2028-10-11
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.